Internal Medicine, Pulmonary Disease · Batesville, AR
NPI
1215196233
Since 2008
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
255 Virginia Dr
Batesville, AR, 72501
Phone (870) 262-1660
Groups this clinician bills Medicare through
Medicare paid, 2024
$117K
3,018 services
Medicare patients, 2024
931
Average age 73
Drug cost, 2024
$2.9M
9,169 prescriptions
Company payments, 2025
$3,437
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Shahla G Naoman was code 99214 (office e&m - established), 817 times for 613 patients. In total Shahla G Naoman billed 3,018 services in 19 codes, and Medicare paid $117K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-07-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 817 | 613 | $62.32 | $51K |
| 94010 Pulmonary Function Testing | Facility | 582 | 548 | $5.38 | $3,131 |
| 94618 Pulmonary Function Testing | Facility | 419 | 416 | $14.57 | $6,107 |
| 99204 Office E&M - New | Facility | 222 | 222 | $86.08 | $19K |
| 99406 Behavioral Health Services | Facility | 135 | 87 | $10.65 | $1,438 |
| 99213 Office E&M - Established | Facility | 122 | 107 | $45.53 | $5,555 |
| 95811 Sleep Study | Facility | 110 | 110 | $82.28 | $9,051 |
| 94060 Pulmonary Function Testing | Facility | 102 | 102 | $6.95 | $709 |
| 95810 Sleep Study | Facility | 100 | 99 | $78.38 | $7,838 |
| 94727 Pulmonary Function Testing | Facility | 100 | 100 | $8.10 | $810 |
| 99214 Office E&M - Established | Office | 87 | 79 | $54.49 | $4,741 |
| 94010 Pulmonary Function Testing | Office | 59 | 59 | $6.04 | $356 |
| 94618 Pulmonary Function Testing | Office | 41 | 41 | $13.04 | $535 |
| 99204 Office E&M - New | Office | 31 | 31 | $76.42 | $2,369 |
| 31624 Bronchoscopy | Facility | 18 | 18 | $62.50 | $1,125 |
By year: 2022 $118K for 2,796 services; 2023 $137K for 3,178 services; 2024 $117K for 3,018 services.
Medicare prescription drug claims, 2024
In 2024, the drug Shahla G Naoman prescribed most often to Medicare patients was Albuterol Sulfate Hfa (Albuterol Sulfate), with 1,516 prescriptions and refills. In total Shahla G Naoman wrote 9,169 Medicare prescriptions that cost $2.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 1,516 | 1,725 | 517 | $42K |
| Montelukast Sodium Generic | 1,360 | 2,072 | 292 | $9,814 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 850 | 966 | 159 | $607K |
| Omeprazole Generic | 443 | 667 | 89 | $4,404 |
| Roflumilast Generic | 409 | 477 | 68 | $44K |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 402 | 470 | 89 | $290K |
| Ventolin Hfa Albuterol Sulfate | 387 | 400 | 131 | $25K |
| Spiriva Respimat Tiotropium Bromide | 376 | 471 | 90 | $249K |
| Symbicort Budesonide/Formoterol Fumarate | 368 | 451 | 84 | $104K |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 295 | 368 | 53 | $170K |
| Incruse Ellipta Umeclidinium Bromide | 280 | 330 | 53 | $111K |
| Azithromycin Generic | 226 | 251 | 99 | $1,481 |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 214 | 242 | 45 | $116K |
| Breo Ellipta Fluticasone/Vilanterol | 204 | 254 | 58 | $96K |
| Prednisone Generic | 187 | 199 | 112 | $516 |
Brand drugs: - claims; generic drugs: 4,636 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Shahla G Naoman $3,437 ($3,437 in general payments such as food, travel and fees) from 15 companies. The largest payer was Inspire Medical Systems, Inc. with $1,468.
| Company | Payments | Amount |
|---|---|---|
| Inspire Medical Systems, Inc. INSP | 9 | $1,468 |
| GlaxoSmithKline, LLC. GSK | 32 | $488 |
| AstraZeneca Pharmaceuticals LP AZN | 21 | $416 |
| Regeneron Healthcare Solutions, Inc. REGN | 12 | $228 |
| Insmed, Inc. INSM | 7 | $170 |
| Verona Pharma, Inc. VRNA | 7 | $138 |
| Genzyme Corporation SNY | 9 | $135 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $98.76 |
| Viatris Specialty LLC | 4 | $85.54 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 4 | $69.37 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.